The Jefferson Oncology Group (JOG) is comprised of physician investigators from within the Jefferson Cancer Network.

JOG was established in 1998 by oncology leaders in the Jefferson Health System seeking to complement the national cooperative group trials and to facilitate participation in Kimmel Cancer Center investigator-initiated trials beyond the Jefferson campus. JOG provides the infrastructure to conduct collaborative clinical cancer research including single-signature contracting and single institutional review board submission.

A list of currently active JOG clinical trials is available.

	Jefferson Cancer Network Hospitals dedicated to further cancer research and improved treatment.  Learn more.			Learn More about the Kimmel Cancer Center at Jefferson			Treatment Explore various cancer treatments offered by Jefferson's CancerCARE